Men’s Health
-
New hope for prostate cancer screening and testing
Scientists have developed a non-invasive blood test to identify how men with advanced prostate cancer will respond to treatment, British researchers have told a conference. Read more
-
Blood enzyme may explain male virus susceptibility
The ACE2 enzyme may help explain why men are more vulnerable to the Covid-19 virus than women, Dutch researchers report today. Read more
-
Lowering androgen may protect against Covid-19
Androgen-deprivation therapy given for prostate cancer may be protective against Covid-19 for these patients, researchers say today. Read more
-
Men and women’s same three heart symptoms
The top three acute coronary symptoms are the same in both women and men, according to a new Dutch study published last night. Read more
-
Hope for non-chemo prostate cancer drug
The breast and ovarian cancer drug olaparib may also be effective against prostate cancer. Read more
-
EU cancer death rate predictions published
Death rates from prostate cancer are predicted to fall across the EU and in the UK – except in Poland, according to predictions published today. Read more
-
Simple test identifies prostate cancer ‘fingerprint’
A simple blood test can identify the ‘fingerprint’ of prostate cancer, which could transform the way doctors monitor tumour behaviour, it was announced last night. Read more
-
Testosterone levels affect risk of metabolic disease and cancers
High testosterone levels may affect the risk of some metabolic diseases and cancers, according to the largest study to date on the genetic regulation of sex hormone levels. Read more
-
Chemotherapy reduction for male cancer patients
Men who undergo surgery for testicular cancer may be able to halve the amount of preventative chemotherapy they take, British researchers have reported. Read more
-
Genetic risk key to prostate screening – study
A successful prostate screening programme could be targeted at men with high genetic risk, according to a new analysis. Read more